JAN 20, 2026

Unlock Early Insights into Drug Discovery

WRITTEN BY: Sarah Hoffman

Unlock Early Insights into Drug Discovery: Analyze 16 Biomarkers to Assess Cell Health with the MILLIPLEX® Human Cell Health Panel

Get insights into cell health by analyzing 16 key biomarkers at once to provide a clear picture of cell health as it relates to cancer research, read the app note, "MILLIPLEX® Human Cell Health Panel as a Screening Tool for Early-Stage Drug Discovery." Gain more insights at SigmaAldrich.com/milliplex-cs.

MilliporeSigma is a partner of Luminex.

MilliporeSigma is the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany.

 

For Research Use Only. Not For Use In Diagnostic Procedures.

© 2026 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved. MilliporeSigma, the vibrant M, Millipore, and MILLIPLEX are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates.